You are currently reviewing an older revision of this page.
M.A. Purdy* Chair Hepeviridae Study Group Division of Viral Hepatitis Centers for Disease Control and Prevention MS-A33 1600 Clifton Rd NE Atlanta, GA 30329 USA (+1)-404-639-2332 email@example.com
T.J. Harrison University College London London, UK T.Harrison@ucl.ac.uk
S. Jameel Wellcome Trust/DBT India Alliance 1110 DLF Tower B, Jasola New Delhi 110025, India (+91)-11-41008402 firstname.lastname@example.org
X-J. Meng College of Veterinary Medicine Virginia Polytechnic Institute and State University Blacksburg, VA USA email@example.com
H. Okamoto Division of Virology Department of Infection and Immunity Jichi Medical University School of Medicine Tochigi-ken, Japan firstname.lastname@example.org
W.H.M. Van der Poel Wageningen Bioveterinary Research Wageningen University and Research Lelystad, The Netherlands Wim.vanderPoel@wur.nl
D.B. Smith, University of Edinburgh Ashworth Laboratories Charlotte Auerbach Road, Edinburgh, EH9 3FL Scotland UK (+44) 131 650 7331 email@example.com
* to whom correspondence should be addressed
The chapter in the Ninth ICTV Report, which served as the template for this chapter, was contributed by Meng, X.J., Anderson, D.A., Arankalle, V.A., Emerson, S.U., Harrison, T.J., Jameel, S. and Okamoto, H.
The contributions to this report by Dr. Purdy do not necessarily represent the official position of the Centers for Disease Control and Prevention. It has not been formally disseminated by the Centers for Disease Control and Prevention/Agency for Toxic Substances and Disease Registry. It does not represent and should not be construed to represent any agency determination or policy.
Support for preparation of the Online Report and Report Summaries has been provided by: